Potential biomarkers for gemcitabine response include the activities of cytidine deaminase ( CDA ) , human equilibrative nucleoside transporter 1 ( hENT1 ) , deoxycytidine kinase ( DCK ) , and ribonucleotide reductase M1 ( RRM1 ) .